Found 154 matching trials
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer
PHASE2This is a phase II Randomized comparison clinical trial of activated CIK ar...
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
CIML NK Cell in Head & Neck Cancer
PHASE1This research study is evaluating the safety and efficacy of a combination ...
Location
Dana Farber Cancer Institute
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
PHASE1This is a Phase 1 open-label, study designed to characterize the safety, to...
Location
Washington University School of Medicine
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer
PHASE2This is a phase II Randomized comparison clinical trial of activated CIK ar...
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Neoantigen-expanded Autologous Immune Cell Therapy
PHASE1The investigators aim to investigate the patient's tumor neoantigen to gene...
Location
Chang Gung Memorial Hospital, Linkou
Safety and Efficacy of γδ T Cell Against Gastric Cancer
PHASE1In this study, safety and effects of γδT cells on human gastric cancer are ...
Location
The First Affiliated Hospital of Guangzhou Medical University
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer
PHASE2This is a phase II Randomized comparison clinical trial of activated CIK ar...
Location
Biological treatment center in Fuda cancer hospital
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
PHASE3To prove that the efficacy and safety of 'Green Cross CELL\* Immuncell-LC g...
Location
Korea University Ansan Hospital
Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
N/AThe goal of this prospective observational cohort study is to assess the op...
Location
Multiple Locations
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer
PHASE2This is a phase II Randomized comparison clinical trial of activated CIK ar...
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital